Next Article in Journal
Hetero-Aggregation of Nanoplastics with Freshwater Algae and the Toxicological Consequences: The Role of Extracellular Polymeric Substances
Previous Article in Journal
Gut–Liver Axis Mediates the Combined Hepatointestinal Toxicity of Triclosan and Polystyrene Microplastics in Mice: Implications for Human Co-Exposure Risks
Previous Article in Special Issue
Atlantic Salmon (Salmo salar) GILL Primary Cell Culture Oxidative Stress and Cellular Damage Response Challenged with Oxytetracycline Antibiotic
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Aquatic Toxicity of Antibiotics Ciprofloxacin and Sulfamethoxazole: Significant Impact on Early Life Stages of Crustaceans, a Marine Diatom, and a Freshwater Plant

Department of Comparative Biomedicine and Food Science (BCA), University of Padova, 35020 Legnaro, Italy
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Toxics 2025, 13(11), 979; https://doi.org/10.3390/toxics13110979
Submission received: 7 October 2025 / Revised: 3 November 2025 / Accepted: 13 November 2025 / Published: 14 November 2025

Abstract

The occurrence of antibiotic residues in the environment is of concern not only because of their contribution to the spread of bacterial resistance, but also due to their possible toxicity to non-target organisms. In this study, the aquatic environmental toxicity of ciprofloxacin (CIP) and sulfamethoxazole (SMX) was assessed in the following model organisms: Daphnia magna and Artemia salina (embryonic and immobilisation test with a 10-d follow-up), Phaeodactylum tricornutum (algal growth inhibition test), and Spirodela polyrhiza (duckweed growth inhibition test). Results showed that among the two saltwater organisms, A. salina was insensitive to both antibiotics, whilst P. tricornutum responded only to SMX with an EC50 of 2.7 mg L−1. In freshwater species, D. magna embryos were more sensitive than juveniles to SMX (EC50 53.8 and 439.2 mg L−1, respectively), whereas the opposite trend was observed for CIP (EC50 95.9 and 15 mg L−1, respectively). S. polyrhiza confirmed the remarkable sensitivity of aquatic plants to fluoroquinolones, with EC50 values between 0.28 and 0.34 mg L−1 depending on the endpoint considered. Notably, this species was also more sensitive to SMX than expected, with EC50 values between 1.5 and 2.5 mg L−1, which are an order of magnitude lower than those typically obtained with Lemna spp. exposed to sulphonamides. Considering the high environmental input of these antibiotics from both human and veterinary treatments, adverse effects on aquatic plants cannot be excluded, potentially leading to ecosystem-level consequences.

1. Introduction

Pharmaceuticals, whilst essential for human and animal health, can have unintended consequences on the environment. After administration, many drugs are excreted unchanged or as active metabolites, entering sewer systems and reaching wastewater treatment plants that are often unable to remove them completely. Unused medications are also improperly disposed of, contributing to environmental contamination. Intensive livestock farming is another major source of pharmaceutical pollution. Antibiotics, in particular, are frequently used for mass medication and considerable quantities can be released into the environment through manure application and agricultural runoff [1]. Once in natural ecosystems, these bioactive substances can interact with non-target organisms, potentially interfering with essential cellular functions and ecological processes. The presence of antibiotics also raises concerns about the spread of antimicrobial resistance, which poses risks to both environmental and public health.
The fluoroquinolone ciprofloxacin (CIP) and the sulphonamide sulfamethoxazole (SMX) are two synthetic antibiotics that have been widely used in human medicine for decades. Due to their relative resistance to degradation [2,3], both compounds are frequently detected in various environmental matrices [4]. Their environmental occurrence is also associated with farming activities. In fact, CIP is the main metabolite of enrofloxacin, commonly used in animal husbandry [5,6], and SMX itself, typically in combination with trimethoprim, is also widely employed. Their veterinary usage is mainly in the form of metaphylactic mass-medication, which implies a relevant environmental drug load and involves various farm settings, including aquaculture [7,8]. Additionally, effluents from pharmaceutical manufacturing facilities have been identified as significant point sources of CIP and SMX contamination in some regions [9,10]. According to a review by Kovalakova et al. [11], the average concentrations of CIP and SMX in surface water are around 103 and 102 ng L−1, respectively, with peak values reaching 107 and 104 ng L−1.
Both CIP and SMX act by inhibiting bacterial DNA synthesis, albeit through distinct molecular mechanisms. However, their limited selectivity can result in adverse effects on non-target organisms [12,13]. Previous ecotoxicity studies conducted by our research group have highlighted intriguing toxicological profiles for other fluoroquinolones and sulphonamides. For example, the fluoroquinolones enrofloxacin, flumequine, and levofloxacin induced embryotoxicity and delayed acute toxicity after neonatal exposure in Daphnia magna [14]. Moreover, chronic exposure to flumequine leads to transgenerational toxicity in this species [15], with several genes related to growth, development, structural components, and antioxidant response significantly modulated [16]. On the other hand, the sulphonamide sulfamethazine, although showing low acute toxicity (EC50 = 202 mg L−1), exhibited pronounced toxicity after a reproduction inhibition test in D. magna, with an estimated EC50 of 4.25 mg L−1; notably, normal reproduction cycles were disrupted, with frequent egg abortion [17]. When it comes to primary producers, fluoroquinolones have demonstrated high toxicity to aquatic plants, with EC50 values ranging from 0.05 to 2.5 mg L−1 [12]. In contrast, sulfonamides tend to be more toxic to algae, showing EC50 values between 0.2 and 43 mg L−1 [18,19].
Given this background, the present study aims to assess the embryonic and neonatal toxicity of CIP and SMX in two crustacean species (D. magna and Artemia salina), as well as their growth inhibition potential in the freshwater duckweed Spirodela polyrhiza and the marine diatom Phaeodactylum tricornutum. To evaluate potential delayed acute effects, toxicity tests on neonate crustaceans included an extended post-exposure observation period of 10 days in clean medium [14]. Furthermore, to increase the sensitivity of the growth inhibition test on S. polyrhiza, various endpoints in addition to frond number were considered, including frond weight, root growth, total frond area, and frond greenness. Beyond comparing sensitivity across taxa and life stages, an additional aim of the present study was to conduct a screening-level risk assessment by deriving provisional freshwater PNEC (Predicted No Effect Concentration) from the most sensitive endpoint and comparing these values and PNEC previously obtained from Species Sensitivity Distribution (SSD) with concentrations reported in environmental monitoring.

2. Materials and Methods

This study utilized four key aquatic model species, D. magna, A. salina, P. tricornutum, and S. polyrhiza, to represent distinct primary trophic levels and environmental compartments, thereby providing a broad overview of antibiotic impacts across aquatic ecosystems.
D. magna and A. salina (both primary consumers) were included as reference invertebrates in ecotoxicological testing, as they are commonly used to evaluate chemical effects in freshwater and saltwater ecosystems. The macrophyte S. polyrhiza and the diatom P. tricornutum were selected to represent primary producers in freshwater and marine compartments, respectively. Notably, S. polyrhiza was chosen over Raphidocelis subcapitata to represent freshwater primary producers because it offers a different level of biological organization and is known to be sensitive to fluoroquinolones, which disrupt DNA and impede photosynthesis [20]. By excluding R. subcapitata from our study, we also took into account that its sensitivity to CIP, SMX, and other antibiotics has been investigated in several studies [21,22]. This combination of species enables a thorough evaluation of sensitivity across primary trophic levels, involving both producers and consumers.

2.1. Chemicals

Analytical-grade Ciprofloxacin, CAS number: 85721-33-1 and purity ≥ 99%, and Sulfamethoxazole, CAS number: 723-46-6 and purity ≥ 98%, were supplied by Sigma-Aldrich (Milan, Italy). Stock solutions of each compound (100 mg L−1) were prepared by gentle stirring overnight at 37 °C in the corresponding test medium. Then, the solutions were stored in the dark at 4 °C until the start of the test. For analytical determination of compound concentrations in test media, Methanol (LC–MS grade) was purchased from Carlo Erba Reagents S.r.l., Milan, Italy; Formic acid (LC–MS grade, purity > 98.0%) and ammonium acetate (ACS reagent, purity ≥ 97%) were obtained from Merck KGaA (Darmstadt, Germany). For the test on D. magna and S. polyrhiza, a 100 mg L−1 stock solution of each compound under investigation was prepared in Rocchetta© water (Rocchetta S.p.A., Gualdo Tadino, Italy; pH 7.6, dry residue 181.6 mg L−1) or in sterile Swedish Standard (SIS) medium, respectively, as specified in OECD Test Guideline 221 [23]. For the tests on A. salina and P. tricornutum, a 100 mg L−1 stock solution of each compound under investigation was prepared in synthetic sea water, in accordance with ISO 10253:2024 [24]. The pH was measured with a BASIC20 pH-meter (CRISON, Carpi, Italy); when necessary, it was adjusted to 7.5 (Rocchetta© water), 6.5 (Swedish Standard (SIS) medium) and 8.0 (synthetic sea water), by adding a few drops of hydrochloric acid or sodium hydroxide solution.

2.2. Phaeodactylum tricornutum Culture Conditions

An axenic strain (1a) of the unicellular alga P. tricornutum, was obtained from the Culture Collection of Algae at the Department of Experimental Phycology, University of Göttingen, Germany. The algae were propagated in sterile synthetic seawater medium, consistent with ISO 10253:2024 [24], supplemented with vitamins B12, B8, and B1 at final concentrations of 1, 1, and 200 µg L−1, respectively. To maintain suspension, filtered air was continuously bubbled through the medium. Cultures were kept under constant illumination (10,000 lux) at a temperature of 20 ± 2 °C. Approximately 10 days before testing, a fresh culture was started to ensure that the algae were in the exponential phase of growth during the experimental procedures. Cell counts were performed daily using a Bürker counting chamber to monitor algal growth; inocula for each test were taken when the logarithmic increase in cell number confirmed exponential growth (doubling time ≈ 24 h). Tests were initiated with approximately 1 × 104 cells mL−1, in line with the recommended starting density by the ISO 10253:2024 guidelines, to maintain exponential growth and prevent transition to the stationary phase over the 72-h exposure.

2.3. Spirodela polyrhiza Culture Conditions

S. polyrhiza turions were initially purchased from MicroBioTests Inc.© (Ghent, Belgium). Upon arrival, they were incubated in T-75 flasks (SARSTEDT®, AG & Co. KG, Nümbrecht, Germany) containing 80 mL of sterile Swedish Standard (SIS) medium at 24 ± 2 °C under fluorescent lighting (10,000 lux) for approximately 3 days to stimulate germination, as described in OECD Test Guideline 221 [23]. Then, the produced fronds were maintained in groups of seven in T-75 flasks filled with sterile SIS medium, kept at 24 ± 2 °C under a lower light intensity (6000 lux). The culture medium was refreshed weekly, and excess fronds were periodically thinned out under a laminar flow hood to prevent contamination. The S. polyrhiza monoculture was maintained under these controlled conditions for at least three months prior to starting the experiments.

2.4. Daphnia magna Culture Conditions

A stable and healthy population of D. magna clones has been maintained in our laboratory for several years. The original stock was sourced from a local supplier. The specific steps taken to establish and maintain this culture are detailed in an earlier publication [25]. Briefly, groups of 50 D. magna individuals were kept in 750 mL of Rocchetta© water, supplemented with 0.01 mg L−1 sodium selenite. The cultures were housed in a temperature-controlled incubator set to 20 ± 1 °C, with a 16-h (100 lux): 8-h dark photoperiod. The crustaceans were fed three times per week, just after water renewal, with Scenedesmus dimorphus, at concentrations of 1.1 × 106 cells/mL up to 4 days of age, 1.3 × 106 cells/mL between 4 and 10 days, and 1.6 × 106 cells/mL thereafter. Over time, the health of the culture was confirmed by low mortality rates (≤2% per week), high reproduction rate (about 15 neonates per brood), and the absence of ephippia and/or males. The cultures were refreshed monthly. To verify the stability of the D. magna population, the sensitivity of the clone to potassium dichromate was monitored at least once every four months.

2.5. Phaeodactylum tricornutum Growth Inhibition Test

The toxicity of the two antibiotics on the unicellular marine alga P. tricornutum was evaluated using a modified version of the ISO 10253:2024 guideline—Marine Algal Growth Inhibition Test [24]. Modifications to the standard protocol included a reduction in vessel and solution volumes: instead of 250 mL Erlenmeyer flasks with 100 mL of medium, flat-bottom P6 plates (SARSTEDT®) were used, each containing 10 mL of test solution. The experimental setup utilized sterile synthetic seawater as the medium, and the light and temperature conditions matched those of the algal culture environment. All experiments were conducted aseptically and in triplicate [26]. A negative control group—comprising six biological replicates with pure synthetic seawater—was included in each assay. The assayed concentrations of CIP were 100, 50, 25, 12.5, 6.25, and 3.13 mg L−1, whilst those of SMX were 15, 5, 1.67, 0.56 and 0.19 mg L−1. After 72-h exposure, algal cell concentrations were determined using a Burker counting chamber and a Keyence VHX-X1-S770E digital microscope (Keyence Corporation, Osaka, Japan). To assess whether the test compounds had algistatic or algicidal properties, a 50 μL aliquot was taken from the concentration that caused the strongest inhibition of algal growth. The aliquot was transferred to fresh synthetic seawater (10 mL) and maintained under standard culture conditions for an additional 9 days. If regrowth occurred, the effect was classified as algistatic; if no regrowth was observed, it was considered algicidal [27]. Since sulphonamides, like SMX, work by inhibiting folate synthesis, it was hypothesized that adding folic acid to the medium might reduce or reverse the growth-inhibiting effects of SMX.
Therefore, a further test was conducted, exposing P. tricornutum to the EC50 of SMX, in the presence of 100 ng L−1 Folic Acid. The concentration of folic acid to be used was established on the basis of a similar experiment conducted previously on the freshwater green alga R. subcapitata [28].

2.6. Spirodela polyrhiza Growth Inhibition Test

Toxicity assessment in the greater duckweed S. polyrhiza was carried out in general accordance with the OECD 221 protocol—Lemna sp. Growth Inhibition Test [23]. The modifications included: (a) the use of a duckweed of the genus Spirodela instead of Lemna; (b) the use of T-75 cell culture flasks (SARSTEDT®) as test vessels, each filled with 80 mL of either test solution or control medium; and (c) the evaluation of multiple endpoints, specifically: frond number, total frond area, root number, average root length, fresh weight and frond colouration. The experiments were conducted under sterile conditions using the Swedish Standard (SIS) medium, with temperature and light settings identical to those used for routine culturing. All tests were performed in triplicate. A negative control group, consisting of three biological replicates in pure SIS medium, was included in each assay. The tested concentrations of SMX and CIP were 2, 0.62, 0.19, 0.06, 0.02 mg L−1. After a 7-d exposure period, fronds and roots were photographed using a Nikon D3400 camera (Nikon Corporation, Tokyo, Japan), and the following parameters were measured using ImageJ® software, version 1.53k (National Institutes of Health, Bethesda, MD, USA): number of fronds, total frond area, number of roots, average root length, and colony greenness. In particular, the greenness of each colony was measured as the ratio between the average G component and the sum of the average R, G and B components [29]. At the end of the test, for fresh weight determination, the plants from each flask were collected, dried with blotting paper and then centrifuged (10’, 3000 RPM) at room temperature in 50 mL tubes containing blotting paper at the bottom. The fronds were then transferred to Eppendorf tubes of known tare, and weighed.

2.7. Artemia salina Acute Immobilisation Test with 10-d Follow-Up

A. salina cysts were initially obtained from a reputable local supplier. Their high quality was confirmed by a hatching success rate exceeding 90%. Seventy-two hours before the acute toxicity tests, the cysts were incubated in synthetic seawater [24] at 24 ± 2 °C under fluorescent light (10,000 lux) to obtain viable nauplii. Given the absence of a standardized protocol for toxicity testing with Artemia, the experimental procedure aligned with the OECD Guideline 202—Daphnia spp., Acute Immobilisation Test [30], supplemented with recommendations from Libralato et al. [31]. This assay evaluates the organisms’ survival following 48 h of exposure. For each antibiotic, five concentrations were prepared in a geometric series with a dilution factor of 2 (100, 50, 25, 12.5, and 6.25 mg L−1). Only A. salina nauplii at developmental stages between instar II and III were used for the test. Acute exposure was conducted in 24-well plates (SARSTEDT®), with 30 individuals per treatment group. After brief rinsing in their respective test solutions, the nauplii were transferred (10 per well) into three wells, each containing 1 mL of test or control solution (synthetic seawater). Incubation was performed in complete darkness at 25 ± 2 °C. Immobilisation was assessed at both 24 and 48 h. Before the test began, a reference group of 30 neonates (not intended for the test) was fixed in 100% ethanol and photographed using a Keyence VHX-X1-S770E digital microscope. Body length (from eye to tail) was measured using the VHX Measurement Data Tabulation Tool software version 3.3.19.528(Keyence Corporation, Osaka, Japan) to establish the average baseline size at time zero.
When unusual swimming behaviour was observed at the end of the acute test, a potential delayed toxicity effect was further assessed. For this purpose, a 10-d post-exposure observation in clean medium was added after the standard 48-h test, during which lethality and daily growth were monitored. For this purpose, at the end of the exposure period, surviving individuals were transferred—maintaining the identity of the treatment—into individual wells of P-6 plates (SARSTEDT®) filled with 10 mL of fresh synthetic seawater. Every other day, dead individuals were counted and removed, the medium was renewed, and the organisms were fed with P. tricornutum at a concentration of 5.3 × 105 cells mL−1. To calculate growth rates, body length was measured for each surviving individual at the end of the 10-day follow-up. The daily growth rate was then determined by subtracting the average baseline length at time zero from each organism’s final body length and dividing the resulting value by the total experimental duration (12 days).

2.8. Daphnia magna Acute Immobilisation Test with 10-d Follow-Up

Acute toxicity testing was carried out following the OECD Guideline 202, Daphnia spp., Acute Immobilisation Test [30], which evaluates the number of immobilised individuals after 24 and 48-h exposure. For each antibiotic tested, five concentrations were prepared in a geometric progression with a dilution factor of 2. Specifically, the concentrations of CIP were 50, 25, 12.5, 6.25 and 3.13 mg L−1, whilst those of SMX were one order of magnitude higher (500, 250, 125, 62.5, and 31.25 mg L−1). Only third to fifth brood neonates aged between 12 and 24 h were used for the tests. They were collected 12 h before the beginning of the test, transferred to a 250 mL beaker with 200 mL of fresh medium, and fed with S. dimorphus at 1.1 × 106 cells mL−1. Although pre-feeding is not specified in the OECD guideline, previous experience has shown it enhances survival in control groups and is therefore advisable [14]. Acute exposure tests were conducted using the 30-well plates provided in the Daphtoxkit F© (MICROBIOTEST, Ghent, Belgium). In alignment with OECD 202 specifications, each treatment group included 20 daphnids. After brief rinsing in their respective solutions, individuals were distributed (five per well) into four wells, each containing 10 mL of either the test solution or the control medium (Rocchetta© water). Temperature and light conditions matched those used in culture maintenance. As indicated by the guideline, after 24 and 48 h the number of immobilised individuals was recorded. Furthermore, to investigate potential delayed effects, an additional 10-d observation period in pure medium was implemented. For this purpose, surviving individuals were transferred, keeping track of their original treatment group, into individual beakers with 50 mL of pure Rocchetta© water. Then, every other day, immobilised individuals were counted and removed, the medium was renewed, and the crustaceans were fed with S. dimorphus (see Section 2.4). Another endpoint considered after the follow-up was the growth rate. Therefore, before the start of the standard 48 h test, 30 neonates (not intended for the test) were preserved in 100% ethanol and photographed under an Olympus CX41 RF microscope equipped with a Nikon D3400 camera. Individual body length (measured from the eye to the base of the tail spine) was determined using ImageJ© software to establish the average baseline length at time zero. The same procedure was applied at the end of the 10-day follow-up for all surviving daphnids. The daily growth rate was calculated for each surviving individual by subtracting the average baseline length at time zero from its body length measured after the 10-day follow-up and dividing the resulting value by the total experimental duration (12 days).

2.9. Artemia salina Cysts Hatching Test

For the embryo hatching assay, A. salina cysts were used. The experimental setup followed an approach that we had previously validated in D. magna [14,15,32], thereby ensuring methodological consistency and interspecies comparisons. The test was conducted in 24-well plates (SARSTEDT®), with 30 cysts assigned to each treatment group. Each antibiotic was tested at five concentrations arranged in a geometric series with a dilution factor of 2 (100, 50, 25, 12.5, and 6.25 mg L−1). Cysts were pre-incubated in pristine seawater for 4 h to allow proper rehydration. Following this step, and after a brief rinse in their respective test solutions, the cysts (n = 30) were randomly distributed (10 per well) into three wells, each containing 1 mL of either test solution or control medium (synthetic seawater). Incubation was carried out over a period of 3 days under standard conditions for A. salina hatching, including controlled light and temperature settings (as described above for the preparation of the acute toxicity test). The number of hatched embryos was recorded at 24-h intervals. Upon completion of the test, all hatched individuals from both exposed and control groups were preserved in pure ethanol for imaging, growth analysis, and malformation assessment.

2.10. Daphnia magna Embryonic Development Test

Given that previous studies had demonstrated embryotoxic effects of the antibiotics Flumequine, Enrofloxacin, and Levofloxacin in D. magna [14,15,32], we extended the investigation to assess the potential embryonic toxicity of CIP and SMX. Since standardized protocols for D. magna embryo or cyst hatching assays are missing, our experimental setup followed previously validated approaches in our lab [14,15,32]. In brief, early-stage embryos (stage 1) were carefully collected from gravid females. This was achieved by gently restraining the adult’s head with a dissecting probe whilst a second probe was used to separate the carapace and release the embryos [33]. Each antibiotic was tested at five concentrations arranged in a geometric series with a dilution factor of 2 (100, 50, 25, 12.5, and 6.25 mg L−1). Embryos were randomly assigned to treatment groups, briefly rinsed in the corresponding test solution, and transferred—three per well—into 24-well plates (SARSTEDT®) containing 1 mL of either test solution or pure Rocchetta© water as a negative control (n = 15). The plates were incubated under standard light and temperature conditions, as already indicated for D. magna culturing. Embryo hatching was monitored daily over a 3-d period. After incubation, all neonates—both from treated and control groups—were preserved in absolute ethanol for subsequent imaging, growth measurement, and morphological assessment.

2.11. Chemical Analysis

At the beginning and end of each test, samples of freshly prepared and spent solutions were taken from the highest and lowest assayed concentrations to evaluate the stability of the two antibiotics. All analyses were performed by liquid chromatography with mass spectrometry detection (LC–MS/MS). The chromatographic separation was achieved using an Accela 600 HPLC pump with CTC automatic injector (Thermo Fischer Scientific, Waltham, MA, USA) equipped with a C18 Kinetex (100 × 2.1 mm, 2.6 μm) analytical column by Phenomenex (Torrance, CA, USA). Chromatographic separation was carried out using a mobile phase consisting of ammonium acetate 0.01 M, pH 2.5 with 0.1% formic acid (eluent A) and Methanol with 0.1% formic acid (eluent B). Optimized separation was obtained using the following gradient program (%A:%B): 80:20 at 0 min, 10:90 at 4 min, held at 10:90 until 6 min, 80:20 at 7 min, held at 80:20 until 9 min to re-equilibrate the system. The flow rate was set at 0.20 mL min−1, and the injection volume was 10 μL. The mass detection was achieved with an LTQ XL ion trap mass spectrometer (Thermo Fischer Scientific, San Jose, CA, USA), equipped with a heated electrospray ionization (HESI-II) probe. The mass spectra were acquired using positive-ion ESI mode. The two precursor ions (MH+) considered for ciprofloxacin and sulfamethoxazole were 332 and 254, respectively. The diagnostic fragments that were monitored for ciprofloxacin (MS3) and sulfamethoxazole (MS2) were m/z 245 and 268 and m/z 156 and 188, respectively. The linearity of response was verified in the 2.5–200 ng/mL range. In order to match this concentration range, samples were accordingly diluted in mobile phase before injection, when necessary.

2.12. Data Analysis

All statistical analyses were performed using GraphPad Prism version 8.4.3. When data consistently meet assumptions of normality, the One-way Anova test was applied, followed by Dunnett’s test, otherwise the non-parametric Kruskal–Wallis test, followed by Dunn’s test, was preferred. Normality of the data was assessed through the Shapiro–Wilk test. p-values were corrected for multiple comparisons, and statistical significance was set at p ≤ 0.05. For D. magna immobilisation, A. salina survival, and S. polyrhiza and P. tricornutum growth inhibition, data were modelled using a four-parameter logistic dose–response curve [34]. Accordingly, median effective concentration (EC50) values and their corresponding confidence intervals (CI) were calculated.

3. Results

Both antibiotics proved to be fairly stable under the various experimental conditions applied (light, temperature, and incubation time). Measured concentrations in freshly prepared test solutions were within 89–105% and 96–109% of the nominal values for CIP and SMX, respectively. Degradation rates, calculated by comparing peaks of fresh and spent solutions, were always below 8% for CIP and below 15% for SMX. Since the concentrations of both compounds remained within ±20% of the nominal values, test results were expressed on a nominal basis.
For the convenience of the reader, the results of the various tests are reported in Supplementary Materials (Table S1, Figure S1), and summarised in a heatmap (Figure 1); toxicity categories were assigned as described in the OECD harmonised system [35]. The growth rate inhibition EC50 of SMX on P. tricornutum was 2.69 (1.82–4.03) mg L−1. The effect was algistatic. It was also verified that when the alga was exposed to this concentration in the presence of 100 ng L−1 folic acid, no attenuation of toxicity occurred, as a growth inhibition of approximately 50% was observed after 72 h. At the assayed concentrations, CIP did not affect P. tricornutum growth. Depending on the endpoint considered, the EC50s of SMX on S. polyrhiza were in the range 0.77–2.52 mg L−1, whilst those of CIP were in the range 0.04–0.34 mg L−1. Particularly with CIP, there was also some significant effect on greenness at the two highest doses tested (Figure 2). The brine shrimp A. salina proved to be very resistant to SMX and CIP toxicity, with no significant acute effects on neonates, even after the 10-d follow-up, and also not in embryos (Figure S1). However, it is important to note the occurrence of certain physical malformations, although not lethal within the 72-h experimental period, in embryos exposed to CIP and SMX. These abnormalities included the absence of the ocellus, missing limbs, and other body deformities (Figure S2). Notably, such malformations were never observed in organisms developed in pure medium. D. magna embryos were instead moderately sensitive to the toxicity of SMX and CIP, with EC50s for development inhibition of 41.27 and 95.93 mg L−1, respectively. In addition, physical malformations have been observed in embryos exposed to CIP and SMX, which, although not lethal within the 72-h experimental period, could potentially exacerbate the toxic effects of these substances over longer exposure times. The abnormalities, never reported in the control group, included the absence or deformation of the ocellus, incomplete development, and other structural deformities (Figure S3). Delayed acute toxicity of SMX was not reported in D. magna juveniles, with similar and very high EC50 values after 48 h and 10 d of follow-up: 470.9 and 439.2, respectively (Figure 3a). On the contrary, CIP showed a remarkable delayed toxicity, with an EC50 of 47.12 mg L−1 after 48 h, which dropped to 14.98 mg L−1 after 10-d follow-up (Figure 3b). Moreover, a slight reduction in D. magna daily growth was observed following exposure to both CIP (50 mg L−1) and SMX (250 mg L−1) (Figure 4).

4. Discussion

According to the review by Zhou et al., sulphonamides are toxic to algae, with EC50s in the range 1.54–32.25 mg L−1 [36]. The toxicity of SMX for P. tricornutum (EC50 of 2.69 mg L−1) reported here is in good agreement with that recently indicated by Feng and colleagues [7] after 96-h exposure (EC50 = 4.65 mg L−1) and, together with data reported by De Orte et al., for sulfadiazine (EC50 = 0.11 mg L−1), confirms the high sensitivity of this marine diatom to sulphonamides [37]. Conversely, the fluoroquinolone CIP showed no toxicity to the marine algae. As for SMX, the addition of folic acid to the culture medium did not limit its toxicity towards P. tricornutum. This indicates that the antibiotic’s inhibition of algal growth may not be due to the inhibition of folate synthesis, but rather to a different mechanism that is distinct from the one responsible for its antimicrobial activity. However, it is also possible that the dose of folic acid added (100 ng L−1) was not sufficient. It is important to highlight that a similar experiment conducted on the freshwater green alga R. subcapitata found that the same concentration of the vitamin could completely reverse the growth inhibition caused by 2.19 mg L−1 of sulfadiazine [28]. Further experiments using higher concentrations of folic acid may clarify these aspects.
Of the several endpoints considered when testing the two antibiotics on S. polyrhiza, root growth was the most sensitive, with a calculated EC50 of 0.77 and 0.04 mg L−1 for SMX and CIP, respectively. These results confirm their high toxicity to aquatic plants [38,39]. Root growth in the case of S. polyrhiza can be a very sensitive endpoint because of the considerable number of roots that this species, unlike Lemna spp., is capable of developing. However, for CIP, all four evaluated endpoints resulted in EC50 values ≤ 0.34 mg L−1, highlighting a considerable level of toxicity. This finding is particularly concerning, as floating macrophytes play a vital role in sustaining the health, balance, and ecological functionality of freshwater ecosystems [40]. Furthermore, floating plants offer numerous ecological benefits to fish, crustaceans, and other aquatic organisms by providing oxygen, food, habitat, and resources, as well as shelter from predators and suitable sites for spawning and juvenile development [41,42]. Consequently, the environmental depletion of these species resulting from CIP contamination could trigger cascading effects throughout the freshwater ecosystem, potentially disrupting trophic interactions and compromising overall ecosystem functionality.
No significant effects were found when testing the two antibiotics on the saltwater crustacean A. salina. Indeed, despite the numerous advantages offered by this species for ecotoxicity tests, i.e., year-round availability without the need for culturing, rapid hatching from durable commercial cysts, population homogeneity, and cost-effectiveness [31], its sensitivity to toxic substances appears to be generally lower than that of Daphnia spp. [43,44,45], at least when considering the classic endpoints. D. magna, instead, was sensitive to both antibiotics. Notably, embryos were more sensitive to SMX, whilst juveniles were more sensitive to CIP. To our knowledge, the toxicity of sulphonamides has never been tested on D. magna embryos; however, in a previous reproduction test conducted with sulfamethazine on D. magna, a strong reproduction inhibition (EC50 = 4.25 mg L−1) was observed, which was consistent with the observation of apparently regular reproduction cycles ending in the abortion of numerous eggs [17]. The embryotoxicity observed in D. magna following exposure to sulphonamides can be mechanistically explained by their inhibition of folic acid synthesis. Sulphonamides competitively inhibit dihydropteroate synthase, a key enzyme in the folate pathway, thereby disrupting the synthesis of purine and pyrimidine nucleotides essential for DNA replication. Since embryonic development involves rapid and continuous cell division, this disruption disproportionately affects embryonic cells, leading to arrested development and egg abortion. In essence, this mode of action makes the early stages of development particularly vulnerable to exposure to sulphonamides. On the other hand, the toxicity of CIP to D. magna juveniles that had been exposed to the drug only during their neonatal life, confirms the ability of fluoroquinolones to exert delayed toxicity after the 48-h acute exposure envisaged by the standard immobilisation test [14]. Indeed, the EC50 calculated after the 10-d follow-up in pure medium (14.98 mg L−1), was more than three times lower than that calculated after the 48-h exposure to CIP (47.12 mg L−1). This result once again highlights the limitations of the acute toxicity test, and suggests that conducting a follow-up in a clean medium could make this standard assay considerably more informative [46]. In contrast, the delayed toxicity of SMX was found to be negligible as the 48-h EC50 (470.9 mg L−1) was very close to that obtained after follow-up (439.2 mg L−1).
In general terms, the toxicity of the two antibiotics does not differ significantly from that of the classes of compounds to which they belong. Among the model organisms on which ecotoxicological assays were performed, the only one strongly sensitive to both drugs was the greater duckweed S. polyrhiza. It can therefore be used as a reference for risk assessment. Applying an assessment factor of 1000 to the EC50 measured for the most sensitive endpoint (inhibition of root growth) yields a freshwater PNEC of 0.77 and 0.04 µg L−1 for SMX and CIP, respectively. In Figure 5, these PNECs and those previously obtained from Species Sensitivity Distribution curves [12,47] are compared to the box plots of the highest concentrations of the two antibiotics detected in surface waters [4]. Notably, environmental concentrations considered in this comparison covered a wide geographical range (African, Asian, European, and American continents) and an extensive time period (approximately from 2006 to 2020). The comparison shows that a risk to the freshwater environment cannot be ruled out, particularly in the case of CIP, where even the least stringent PNEC, obtained from the SSD curve, is exceeded in nearly 25% of the waters analysed. Moreover, on a global scale, CIP would have a frighteningly high GWF (Grey Water Footprint): 1900 m3·yr−1 on a per capita basis [48]. And this value is probably understated as the CIP environmental load coming from the metabolism of enrofloxacin, a largely used veterinary fluoroquinolone, was not originally included in the calculation [49].

5. Conclusions

This study provides new insights into the aquatic toxicity of CIP and SMX, focusing on primary producers and primary consumers. Among the organisms tested, the freshwater macrophyte S. polyrhiza emerged as the most sensitive species, with EC50 values in the sub-mg L−1 range, particularly for root growth inhibition. These findings reinforce the role of aquatic plants as critical sentinels for antibiotic pollution, given their ecological importance for habitat provision, nutrient cycling, and food-web stability [40,41]. In contrast, the marine alga P. tricornutum displayed significant sensitivity to SMX but not to CIP, whereas the brine shrimp A. salina was largely insensitive to both compounds. Lastly, D. magna showed intermediate sensitivity, with embryos affected by SMX and juveniles by CIP, the latter also exhibiting delayed toxicity beyond the standard acute test period. This underscores the importance of including extended post-exposure observations to capture sublethal and latent effects that would otherwise remain undetected.
From a regulatory perspective, the PNECs derived from S. polyrhiza data (0.77 µg L−1 for SMX and 0.04 µg L−1 for CIP) are exceeded by reported environmental concentrations, especially for CIP. This points to a tangible ecological risk in freshwater systems, where communities of aquatic macrophytes function as keystone components, and their impairment could cascade across trophic levels.
Overall, the results confirm that fluoroquinolones and sulphonamides, despite their distinct modes of action, can both impair early life stages of invertebrates and compromise the growth of aquatic primary producers. Given their widespread use and persistence in the environment, the ecological footprint of these antibiotics should not be underestimated. Future risk assessments would benefit from (i) considering sensitive endpoints such as root growth in macrophytes, (ii) extending acute toxicity protocols with post-exposure follow-ups, and (iii) integrating mixture toxicity and chronic exposure scenarios to better reflect environmental conditions.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/toxics13110979/s1, Figure S1: Effects of CIP and SMX on A. salina and D. magna growth rate, hatching rate and embryos development; Figure S2: Examples of living A. salina embryos observed at the end of the 72-h hatching test; Figure S3. Examples of living D. magna embryos observed at the end of the 72-h hatching test; Table S1: Summary of the test results.

Author Contributions

Conceptualization, E.P., R.Z. and M.D.L.; formal analysis, E.P., R.Z., M.P. and M.D.L.; investigation, E.P., R.Z., M.S., G.M., R.M.L. and L.L.; writing—original draft preparation, E.P., R.Z. and M.D.L.; writing—review and editing, M.P.; supervision, M.P. and M.D.L.; project administration, M.P. and M.D.L.; funding acquisition, M.P. and M.D.L. All authors have read and agreed to the published version of the manuscript.

Funding

R.Z. was supported by a Ph.D. fellowship funded by the Italian Ministry of University and Research (MUR) through the Department of Excellence program (2023–2027), within the project ‘Animals and Environment: Toward a Sustainable Life (SENTINEL)’.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors on request.

Acknowledgments

During the preparation of this manuscript, the authors used ChatGpt (GPT-5, OpenAI) for language editing purposes. The authors have reviewed and edited the output and take full responsibility for the content of this publication.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
CIPCiprofloxacin
SMXSulfamethoxazole
EC50Median Effective Concentration
PNECPredicted No-Effect Concentration
SSDSpecies Sensitivity Distribution

References

  1. Saeed, H.; Padmesh, S.; Singh, A.; Nandy, A.; Singh, S.P.; Deshwal, R.K. Impact of Veterinary Pharmaceuticals on Environment and Their Mitigation through Microbial Bioremediation. Front. Microbiol. 2024, 15, 1396116. [Google Scholar] [CrossRef]
  2. Van Doorslaer, X.; Dewulf, J.; Van Langenhove, H.; Demeestere, K. Fluoroquinolone Antibiotics: An Emerging Class of Environmental Micropollutants. Sci. Total Environ. 2014, 500–501, 250–269. [Google Scholar] [CrossRef]
  3. Sukul, P.; Spiteller, M. Sulfonamides in the environment as veterinary drugs. In Reviews of Environmental Contamination and Toxicology; Ware, G.W., Ed.; Springer: New York, NY, USA, 2006; Volume 187, pp. 67–101. [Google Scholar] [CrossRef]
  4. Graumnitz, S.; Jungmann, D. The Database “Pharmaceuticals in the Environment” Update for the Period 2017–2020; German Environment Agency (Umweltbundesamt): Dessau-Roßlau, Germany, 2021. Available online: https://www.umweltbundesamt.de/en/publikationen/the-database-pharmaceuticals-in-the-environment-0 (accessed on 27 September 2025).
  5. Knapp, C.W.; Cardoza, L.A.; Hawes, J.N.; Wellington, E.M.H.; Larive, C.K.; Graham, D.W. Fate and Effects of Enrofloxacin in Aquatic Systems under Different Light Conditions. Environ. Sci. Technol. 2005, 39, 9140–9146. [Google Scholar] [CrossRef]
  6. Li, Y.; Niu, J.; Wang, W. Photolysis of Enrofloxacin in Aqueous Systems under Simulated Sunlight Irradiation: Kinetics, Mechanism and Toxicity of Photolysis Products. Chemosphere 2011, 85, 892–897. [Google Scholar] [CrossRef]
  7. Xi, F. The Enrofloxacin Pollution Control from Fish to Environment. Mar. Pollut. Bull. 2024, 199, 115923. [Google Scholar] [CrossRef]
  8. Wang, Q.; Zhou, X.; Jin, Q.; Zhu, F. Effects of the Aquatic Pollutant Sulfamethoxazole on the Innate Immunity and Antioxidant Capacity of the Mud Crab Scylla Paramamosain. Chemosphere 2024, 349, 140775. [Google Scholar] [CrossRef] [PubMed]
  9. Larsson, D.G.J.; de Pedro, C.; Paxeus, N. Effluent from Drug Manufactures Contains Extremely High Levels of Pharmaceuticals. J. Hazard. Mater. 2007, 148, 751–755. [Google Scholar] [CrossRef]
  10. Lin, A.Y.-C.; Yu, T.-H.; Lin, C.-F. Pharmaceutical Contamination in Residential, Industrial, and Agricultural Waste Streams: Risk to Aqueous Environments in Taiwan. Chemosphere 2008, 74, 131–141. [Google Scholar] [CrossRef] [PubMed]
  11. Kovalakova, P.; Cizmas, L.; McDonald, T.J.; Marsalek, B.; Feng, M.; Sharma, V.K. Occurrence and Toxicity of Antibiotics in the Aquatic Environment: A Review. Chemosphere 2020, 251, 126351. [Google Scholar] [CrossRef] [PubMed]
  12. Pauletto, M.; De Liguoro, M. A Review on Fluoroquinolones’ Toxicity to Freshwater Organisms and a Risk Assessment. J. Xenobiot. 2024, 14, 717–752. [Google Scholar] [CrossRef]
  13. Białk-Bielińska, A.; Stepnowski, P.; Kumirska, J. What Do We Know about the Chronic and Mixture Toxicity of the Residues of Sulfonamides in the Environment? In Organic Pollutants—Monitoring, Risk and Treatment; Rashed, M.N., Ed.; InTech: Rijeka, Croatia, 2013. [Google Scholar] [CrossRef]
  14. Tolosi, R.; De Liguoro, M. Delayed Toxicity of Three Fluoroquinolones and Their Mixtures after Neonatal or Embryonic Exposure, in Daphnia Magna. Ecotoxicol. Environ. Saf. 2021, 225, 112778. [Google Scholar] [CrossRef] [PubMed]
  15. De Liguoro, M.; Maraj, S.; Merlanti, R. Transgenerational Toxicity of Flumequine over Four Generations of Daphnia Magna. Ecotoxicol. Environ. Saf. 2019, 169, 814–821. [Google Scholar] [CrossRef] [PubMed]
  16. Pietropoli, E.; Pauletto, M.; Tolosi, R.; Iori, S.; Lopparelli, R.M.; Montanucci, L.; Giantin, M.; Dacasto, M.; De Liguoro, M. An In Vivo Whole-Transcriptomic Approach to Assess Developmental and Reproductive Impairments Caused by Flumequine in Daphnia Magna. Int. J. Mol. Sci. 2023, 24, 9396. [Google Scholar] [CrossRef]
  17. De Liguoro, M.; Fioretto, B.; Poltronieri, C.; Gallina, G. The Toxicity of Sulfamethazine to Daphnia Magna and Its Additivity to Other Veterinary Sulfonamides and Trimethoprim. Chemosphere 2009, 75, 1519–1524. [Google Scholar] [CrossRef]
  18. De Liguoro, M.; Di Leva, V.; Gallina, G.; Faccio, E.; Pinto, G.; Pollio, A. Evaluation of the Aquatic Toxicity of Two Veterinary Sulfonamides Using Five Test Organisms. Chemosphere 2010, 81, 788–793. [Google Scholar] [CrossRef]
  19. Duan, W.; Cui, H.; Jia, X.; Huang, X. Occurrence and Ecotoxicity of Sulfonamides in the Aquatic Environment: A Review. Sci. Total Environ. 2022, 820, 153178. [Google Scholar] [CrossRef] [PubMed]
  20. Zhao, X.-L.; Li, P.; Qu, C.; Lu, R.; Li, Z.-H. Phytotoxicity of Environmental Norfloxacin Concentrations on the Aquatic Plant Spirodela polyrrhiza: Evaluation of Growth Parameters, Photosynthetic Toxicity and Biochemical Traits. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2022, 258, 109365. [Google Scholar] [CrossRef]
  21. Chang, F.; Yi, M.; Li, H.; Wang, J.; Zhao, X.; Hu, X.; Qi, Q. Antibiotic Toxicity Isolated and as Binary Mixture to Freshwater Algae Raphidocelis subcapitata: Growth Inhibition, Prediction Model, and Environmental Risk Assessment. Toxics 2022, 10, 739. [Google Scholar] [CrossRef]
  22. Yang, L.H.; Ying, G.G.; Su, H.C.; Stauber, J.L.; Adams, M.S.; Binet, M.T. Growth-Inhibiting Effects of 12 Antibacterial Agents and Their Mixtures on the Freshwater Microalga Pseudokirchneriella subcapitata. Environ. Toxicol. Chem. 2008, 27, 1201–1208. [Google Scholar] [CrossRef]
  23. Organisation for Economic Co-operation and Development (OECD). Test No. 221: Lemna sp. Growth Inhibition Test; OECD Publishing: Paris, France, 2006. [Google Scholar] [CrossRef]
  24. ISO 10253:2024; Water Quality—Marine Algal Growth Inhibition Test with Skeletonema sp. and Phaeodactylum tricornutum. International Organization for Standardization (ISO): Geneva, Switzerland, 2024. Available online: https://www.iso.org/standard/85458.html (accessed on 27 September 2025).
  25. Pietropoli, E.; Bardhi, A.; Simonato, V.; Zanella, M.; Iori, S.; Barbarossa, A.; Giantin, M.; Dacasto, M.; De Liguoro, M.; Pauletto, M. Comparative Toxicity Assessment of Alternative versus Legacy PFAS: Implications for Two Primary Trophic Levels in Freshwater Ecosystems. J. Hazard. Mater. 2024, 477, 135269. [Google Scholar] [CrossRef]
  26. Environment Canada. Biological Test Method: Growth Inhibition Test Using a Freshwater Alga, 2nd ed.; Report EPS 1/RM/25; Environment Canada: Ottawa, ON, Canada, 2007. Available online: https://www.canada.ca/en/environment-climate-change/services/wildlife-research-landscape-science/biological-test-method-publications/growth-inhibition-test-freshwater-alga.html (accessed on 27 September 2025).
  27. United States Environmental Protection Agency (US EPA). Ecological Effects Test Guidelines: OCSPP 850.4500—Algal Toxicity; EPA 712-C-006; Office of Chemical Safety and Pollution Prevention: Washington, DC, USA, 2012. Available online: https://www.regulations.gov/document/EPA-HQ-OPPT-2009-0154-0003 (accessed on 27 September 2025).
  28. Eguchi, K.; Nagase, H.; Ozawa, M.; Endoh, Y.S.; Goto, K.; Hirata, K.; Miyamoto, K.; Yoshimura, H. Evaluation of Antimicrobial Agents for Veterinary Use in the Ecotoxicity Test Using Microalgae. Chemosphere 2004, 57, 1733–1738. [Google Scholar] [CrossRef]
  29. Richardson, A.D.; Jenkins, J.P.; Braswell, B.H.; Hollinger, D.Y.; Ollinger, S.V.; Smith, M.-L. Use of Digital Webcam Images to Track Spring Green-up in a Deciduous Broadleaf Forest. Oecologia 2007, 152, 323–334. [Google Scholar] [CrossRef]
  30. Organisation for Economic Co-operation and Development (OECD). Test No. 202: Daphnia sp. Acute Immobilisation Test; OECD Guidelines for the Testing of Chemicals, Section 2; OECD Publishing: Paris, France, 2004. [Google Scholar] [CrossRef]
  31. Libralato, G.; Prato, E.; Migliore, L.; Cicero, A.M.; Manfra, L. A Review of Toxicity Testing Protocols and Endpoints with Artemia spp. Ecol. Indic. 2016, 69, 35–49. [Google Scholar] [CrossRef]
  32. Dalla Bona, M.; Lizzi, F.; Borgato, A.; De Liguoro, M. Increasing Toxicity of Enrofloxacin over Four Generations of Daphnia Magna. Ecotoxicol. Environ. Saf. 2016, 132, 397–402. [Google Scholar] [CrossRef]
  33. LeBlanc, G.A.; Mu, X.; Rider, C.V. Embryotoxicity of the Alkylphenol Degradation Product 4-Nonylphenol to the Crustacean Daphnia Magna. Environ. Health Perspect. 2000, 108, 1133–1138. [Google Scholar] [CrossRef]
  34. Ritz, C. Toward a Unified Approach to Dose–Response Modeling in Ecotoxicology. Environ. Toxicol. Chem. 2010, 29, 220–229. [Google Scholar] [CrossRef]
  35. Organisation for Economic Co-operation and Development (OECD). Harmonised Integrated Classification System for Human Health and Environmental Hazards of Chemical Substances and Mixtures; OECD Series on Testing and Assessment, No. 33; OECD Publishing: Paris, France, 2001. Available online: https://ntp.niehs.nih.gov/sites/default/files/iccvam/suppdocs/feddocs/oecd/oecd_hclfinaw.pdf (accessed on 1 October 2025).
  36. Zhou, J.; Yun, X.; Wang, J.; Li, Q.; Wang, Y. A Review on the Ecotoxicological Effect of Sulphonamides on Aquatic Organisms. Toxicol. Rep. 2022, 9, 534–540. [Google Scholar] [CrossRef]
  37. de Orte, M.R.; Carballeira, C.; Viana, I.G.; Carballeira, A. Assessing the Toxicity of Chemical Compounds Associated with Marine Land-Based Fish Farms: The Use of Mini-Scale Microalgal Toxicity Tests. Chem. Ecol. 2013, 29, 554–563. [Google Scholar] [CrossRef]
  38. Brain, R.A.; Johnson, D.J.; Richards, S.M.; Sanderson, H.; Sibley, P.K.; Solomon, K.R. Effects of 25 Pharmaceutical Compounds to Lemna Gibba Using a Seven-day Static-renewal Test. Environ. Toxicol. Chem. 2004, 23, 371–382. [Google Scholar] [CrossRef]
  39. Ebert, I.; Bachmann, J.; Kühnen, U.; Küster, A.; Kussatz, C.; Maletzki, D.; Schlüter, C. Toxicity of the Fluoroquinolone Antibiotics Enrofloxacin and Ciprofloxacin to Photoautotrophic Aquatic Organisms. Environ. Toxicol. Chem. 2011, 30, 2786–2792. [Google Scholar] [CrossRef]
  40. Goala, M.; Bachheti, A.; Kumar Arya, A.; Kumar, V. A Review on the Role of Duckweed (Lemna spp.) in the Rejuvenation of Aquatic Bodies by Pollutant Remediation and Recovery of Valuable Resources. Environ. Monit. Assess. 2025, 197, 591. [Google Scholar] [CrossRef]
  41. Meerhoff, M.; Mazzeo, N.; Moss, B.; Rodríguez-Gallego, L. The Structuring Role of Free-Floating versus Submerged Plants in a Subtropical Shallow Lake. Aquat. Ecol. 2003, 37, 377–391. [Google Scholar] [CrossRef]
  42. Lesiv, M.S.; Polishchuk, A.I.; Antonyak, H.L. Aquatic Macrophytes: Ecological Features and Functions. Biol. Stud. 2020, 14, 79–94. [Google Scholar] [CrossRef]
  43. Macri, A.; Stazi, A.V.; Dojmi Di Delupis, G. Acute Toxicity of Furazolidone onArtemia Salina, Daphnia Magna, andCulex Pipiens Molestus Larvae. Ecotoxicol. Environ. Saf. 1988, 16, 90–94. [Google Scholar] [CrossRef] [PubMed]
  44. Toussaint, M.W.; Shedd, T.R.; van der Schalie, W.H.; Leather, G.R. A Comparison of Standard Acute Toxicity Tests with Rapid-screening Toxicity Tests. Environ. Toxicol. Chem. 1995, 14, 907–915. [Google Scholar] [CrossRef]
  45. Minguez, L.; Di Poi, C.; Farcy, E.; Ballandonne, C.; Benchouala, A.; Bojic, C.; Cossu-Leguille, C.; Costil, K.; Serpentini, A.; Lebel, J.-M.; et al. Comparison of the Sensitivity of Seven Marine and Freshwater Bioassays as Regards Antidepressant Toxicity Assessment. Ecotoxicology 2014, 23, 1744–1754. [Google Scholar] [CrossRef] [PubMed]
  46. Jager, T. Identifying and Predicting Delayed Mortality with Toxicokinetic-Toxicodynamic Models. Environ. Toxicol. Chem. 2024, 43, 1030–1035. [Google Scholar] [CrossRef]
  47. Fan, H.; Wang, Y.; Liu, X.; Wang, Y.Y.L.; Kazmi, S.S.U.H.; Ohore, O.E.; Liu, W.; Wang, Z. Derivation of Predicted No-Effect Concentrations for Thirty-Five Pharmaceuticals and Personal Care Products in Freshwater Ecosystem. Front. Mar. Sci. 2022, 9, 1043792. [Google Scholar] [CrossRef]
  48. Wöhler, L.; Niebaum, G.; Krol, M.; Hoekstra, A.Y. The Grey Water Footprint of Human and Veterinary Pharmaceuticals. Water Res. X 2020, 7, 100044. [Google Scholar] [CrossRef] [PubMed]
  49. Oldenkamp, R.; Beusen, A.H.W.; Huijbregts, M.A.J. Aquatic Risks from Human Pharmaceuticals—Modelling Temporal Trends of Carbamazepine and Ciprofloxacin at the Global Scale. Environ. Res. Lett. 2019, 14, 034003. [Google Scholar] [CrossRef]
Figure 1. Heatmap reporting the estimated EC50 values (mg L−1) for sulfamethoxazole (SMX) and ciprofloxacin in each test in the four model organisms: P. tricornutum (P.t.), S. polyrhiza (S.p.), A. salina (A.s.), D. magna (D.m.). The colour gradient reflects the EC50 value, ranging from low (red, very toxic) to high (pinkish white, non-toxic), with intermediate shades indicating toxic (pale red) and harmful (pink) levels, according to the OECD harmonised system [35]. Created with BioRender.com and Flourish.
Figure 1. Heatmap reporting the estimated EC50 values (mg L−1) for sulfamethoxazole (SMX) and ciprofloxacin in each test in the four model organisms: P. tricornutum (P.t.), S. polyrhiza (S.p.), A. salina (A.s.), D. magna (D.m.). The colour gradient reflects the EC50 value, ranging from low (red, very toxic) to high (pinkish white, non-toxic), with intermediate shades indicating toxic (pale red) and harmful (pink) levels, according to the OECD harmonised system [35]. Created with BioRender.com and Flourish.
Toxics 13 00979 g001
Figure 2. Greenness of Spirodela polyrhiza after 7 days of exposure to sulfamethoxazole (SMX) and ciprofloxacin (CIP). Colony greenness is the ratio between the average green (G) component and the sum of the average red (R), green (G) and blue (B) components [29]. K = control. Error bars show standard error. * Significantly different from the control (p < 0.05); ** significantly different from the control (p < 0.01); *** significantly different from the control (p < 0.001); one-way Anova followed by Dunnett’s post hoc test.
Figure 2. Greenness of Spirodela polyrhiza after 7 days of exposure to sulfamethoxazole (SMX) and ciprofloxacin (CIP). Colony greenness is the ratio between the average green (G) component and the sum of the average red (R), green (G) and blue (B) components [29]. K = control. Error bars show standard error. * Significantly different from the control (p < 0.05); ** significantly different from the control (p < 0.01); *** significantly different from the control (p < 0.001); one-way Anova followed by Dunnett’s post hoc test.
Toxics 13 00979 g002
Figure 3. Survival curves of D. magna over 48-h exposure to (a) sulfamethoxazole (SMX) and (b) ciprofloxacin (CIP), with 10-d follow-up in pure medium. Error bars show standard error.
Figure 3. Survival curves of D. magna over 48-h exposure to (a) sulfamethoxazole (SMX) and (b) ciprofloxacin (CIP), with 10-d follow-up in pure medium. Error bars show standard error.
Toxics 13 00979 g003
Figure 4. Daily growth of D. magna over 12 days, i.e., 2 days of exposure to (a) sulfamethoxazole (SMX) and (b) ciprofloxacin (CIP), plus an additional 10-d follow-up in pure medium. K = control; n.d. = no data available (almost all the exposed animals died during the experiment). Error bars show standard error. * Significantly different from the control (p < 0.05); ** significantly different from the control (p < 0.01); one-way Anova followed by Dunnett’s post hoc test.
Figure 4. Daily growth of D. magna over 12 days, i.e., 2 days of exposure to (a) sulfamethoxazole (SMX) and (b) ciprofloxacin (CIP), plus an additional 10-d follow-up in pure medium. K = control; n.d. = no data available (almost all the exposed animals died during the experiment). Error bars show standard error. * Significantly different from the control (p < 0.05); ** significantly different from the control (p < 0.01); one-way Anova followed by Dunnett’s post hoc test.
Toxics 13 00979 g004
Figure 5. Box plot of the maximum concentrations reported per study in freshwater environments for ciprofloxacin (CIP) and sulfamethoxazole (SMX) [12]. Red dots are the Predicted No Effect Concentration (PNEC) values obtained from the current experimentation; yellow dots are the PNEC values previously obtained from Species Sensitivity Distribution curves.
Figure 5. Box plot of the maximum concentrations reported per study in freshwater environments for ciprofloxacin (CIP) and sulfamethoxazole (SMX) [12]. Red dots are the Predicted No Effect Concentration (PNEC) values obtained from the current experimentation; yellow dots are the PNEC values previously obtained from Species Sensitivity Distribution curves.
Toxics 13 00979 g005
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Pietropoli, E.; Zgheib, R.; Selmo, M.; Melotto, G.; Lopparelli, R.M.; Lucatello, L.; Pauletto, M.; De Liguoro, M. Aquatic Toxicity of Antibiotics Ciprofloxacin and Sulfamethoxazole: Significant Impact on Early Life Stages of Crustaceans, a Marine Diatom, and a Freshwater Plant. Toxics 2025, 13, 979. https://doi.org/10.3390/toxics13110979

AMA Style

Pietropoli E, Zgheib R, Selmo M, Melotto G, Lopparelli RM, Lucatello L, Pauletto M, De Liguoro M. Aquatic Toxicity of Antibiotics Ciprofloxacin and Sulfamethoxazole: Significant Impact on Early Life Stages of Crustaceans, a Marine Diatom, and a Freshwater Plant. Toxics. 2025; 13(11):979. https://doi.org/10.3390/toxics13110979

Chicago/Turabian Style

Pietropoli, Edoardo, Rebecca Zgheib, Marco Selmo, Giacomo Melotto, Rosa Maria Lopparelli, Lorena Lucatello, Marianna Pauletto, and Marco De Liguoro. 2025. "Aquatic Toxicity of Antibiotics Ciprofloxacin and Sulfamethoxazole: Significant Impact on Early Life Stages of Crustaceans, a Marine Diatom, and a Freshwater Plant" Toxics 13, no. 11: 979. https://doi.org/10.3390/toxics13110979

APA Style

Pietropoli, E., Zgheib, R., Selmo, M., Melotto, G., Lopparelli, R. M., Lucatello, L., Pauletto, M., & De Liguoro, M. (2025). Aquatic Toxicity of Antibiotics Ciprofloxacin and Sulfamethoxazole: Significant Impact on Early Life Stages of Crustaceans, a Marine Diatom, and a Freshwater Plant. Toxics, 13(11), 979. https://doi.org/10.3390/toxics13110979

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop